{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:39:58Z","timestamp":1787755198043,"version":"build-2784847793"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Bone and Joint Surgery"],"published-print":{"date-parts":[[2017,4,19]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      The medical treatment of periprosthetic joint infection (PJI) involves prolonged systemic antibiotic courses, often with suboptimal clinical outcomes including increased morbidity and health-care costs. Oral and intravenous monotherapies and combination antibiotic regimens were evaluated in a mouse model of methicillin-resistant\n                      <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic>\n                      (MRSA) PJI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Oral linezolid with or without oral rifampin, intravenous vancomycin with oral rifampin, intravenous daptomycin or ceftaroline with or without oral rifampin, oral doxycycline, or sham treatment were administered at human-exposure doses for 6 weeks in a mouse model of PJI. Bacterial burden was assessed by in vivo bioluminescent imaging and ex vivo counting of colony-forming units (CFUs), and reactive bone changes were evaluated with radiographs and micro-computed tomography (\u03bcCT) imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Oral-only linezolid-rifampin and all intravenous antibiotic-rifampin combinations resulted in no recoverable bacteria and minimized reactive bone changes. Although oral linezolid was the most effective monotherapy, all oral and intravenous antibiotic monotherapies failed to clear infection or prevent reactive bone changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Combination antibiotic-rifampin regimens, including oral-only linezolid-rifampin and the newer ceftaroline-rifampin combinations, were highly effective and more efficacious than monotherapies when used against a preclinical MRSA PJI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Relevance:<\/jats:title>\n                    <jats:p>This study provides important preclinical evidence to better optimize future antibiotic therapy against PJIs. In particular, the oral-only linezolid-rifampin option might reduce venous access complications and health-care costs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.16.01002","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T09:51:40Z","timestamp":1492595500000},"page":"656-665","source":"Crossref","is-referenced-by-count":58,"title":["Oral-Only Linezolid-Rifampin Is Highly Effective Compared with Other Antibiotics for Periprosthetic Joint Infection"],"prefix":"10.2106","volume":"99","author":[{"given":"John M.","family":"Thompson","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery (J.M.T., R.S.S., and L.S.M.), Department of Pediatrics (V.S., A.A.O., and S.K.J.), Center for Infection and Inflammation Imaging Research (V.S., A.A.O., and S.K.J.), Department of Dermatology (A.G.A., R.J.M., R.V.O., Y.W., and L.S.M.), and Division of Infectious Diseases, Department of Medicine (L.S.M.), Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Saini","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery (J.M.T., R.S.S., and L.S.M.), Department of Pediatrics (V.S., A.A.O., and S.K.J.), Center for Infection and Inflammation Imaging Research (V.S., A.A.O., and S.K.J.), Department of Dermatology (A.G.A., R.J.M., R.V.O., Y.W., and L.S.M.), and Division of Infectious Diseases, Department of Medicine (L.S.M.), Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa G.","family":"Ashbaugh","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery (J.M.T., R.S.S., and L.S.M.), Department of Pediatrics (V.S., A.A.O., and S.K.J.), Center for Infection and Inflammation Imaging Research (V.S., A.A.O., and S.K.J.), Department of Dermatology (A.G.A., R.J.M., R.V.O., Y.W., and L.S.M.), and Division of Infectious Diseases, Department of Medicine (L.S.M.), Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery (J.M.T., R.S.S., and L.S.M.), Department of Pediatrics (V.S., A.A.O., and S.K.J.), Center for Infection and Inflammation Imaging Research (V.S., A.A.O., and S.K.J.), Department of Dermatology (A.G.A., R.J.M., R.V.O., Y.W., and L.S.M.), and Division of Infectious Diseases, Department of Medicine (L.S.M.), Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro A.","family":"Ordonez","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery (J.M.T., R.S.S., and L.S.M.), Department of Pediatrics (V.S., A.A.O., and S.K.J.), Center for Infection and Inflammation Imaging Research (V.S., A.A.O., and S.K.J.), Department of Dermatology (A.G.A., R.J.M., R.V.O., Y.W., and L.S.M.), and Division of Infectious Diseases, Department of Medicine (L.S.M.), Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger V.","family":"Ortines","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery (J.M.T., R.S.S., and L.S.M.), Department of Pediatrics (V.S., A.A.O., and S.K.J.), Center for Infection and Inflammation Imaging Research (V.S., A.A.O., and S.K.J.), Department of Dermatology (A.G.A., R.J.M., R.V.O., Y.W., and L.S.M.), and Division of Infectious Diseases, Department of Medicine (L.S.M.), Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery (J.M.T., R.S.S., and L.S.M.), Department of Pediatrics (V.S., A.A.O., and S.K.J.), Center for Infection and Inflammation Imaging Research (V.S., A.A.O., and S.K.J.), Department of Dermatology (A.G.A., R.J.M., R.V.O., Y.W., and L.S.M.), and Division of Infectious Diseases, Department of Medicine (L.S.M.), Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Sterling","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery (J.M.T., R.S.S., and L.S.M.), Department of Pediatrics (V.S., A.A.O., and S.K.J.), Center for Infection and Inflammation Imaging Research (V.S., A.A.O., and S.K.J.), Department of Dermatology (A.G.A., R.J.M., R.V.O., Y.W., and L.S.M.), and Division of Infectious Diseases, Department of Medicine (L.S.M.), Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K.","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery (J.M.T., R.S.S., and L.S.M.), Department of Pediatrics (V.S., A.A.O., and S.K.J.), Center for Infection and Inflammation Imaging Research (V.S., A.A.O., and S.K.J.), Department of Dermatology (A.G.A., R.J.M., R.V.O., Y.W., and L.S.M.), and Division of Infectious Diseases, Department of Medicine (L.S.M.), Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd S.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery (J.M.T., R.S.S., and L.S.M.), Department of Pediatrics (V.S., A.A.O., and S.K.J.), Center for Infection and Inflammation Imaging Research (V.S., A.A.O., and S.K.J.), Department of Dermatology (A.G.A., R.J.M., R.V.O., Y.W., and L.S.M.), and Division of Infectious Diseases, Department of Medicine (L.S.M.), Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"5418","key":"bib1-20230714","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science."},{"issue":"8","key":"bib2-20230714","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJMcp0905029","article-title":"Clinical practice. Infection associated with prosthetic joints","volume":"361","author":"Del Pozo","year":"2009","journal-title":"N Engl J Med."},{"issue":"14","key":"bib3-20230714","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.2106\/JBJS.K.00011","article-title":"Adverse outcomes in hip arthroplasty: long-term trends","volume":"94","author":"Wolf","year":"2012","journal-title":"J Bone Joint Surg Am."},{"issue":"8","key":"bib4-20230714","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.arth.2012.02.022","article-title":"Economic burden of periprosthetic joint infection in the United States","volume":"27","author":"Kurtz","year":"2012","journal-title":"J Arthroplasty."},{"issue":"1","key":"bib5-20230714","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis."},{"issue":"12","key":"bib6-20230714","doi-asserted-by":"crossref","first-page":"771","DOI":"10.5435\/00124635-201012000-00007","article-title":"AAOS clinical practice guideline: diagnosis and treatment of periprosthetic joint infections of the hip and knee","volume":"18","author":"Parvizi","year":"2010","journal-title":"J Am Acad Orthop Surg."},{"issue":"2","key":"bib7-20230714","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/cid\/cis746","article-title":"A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention","volume":"56","author":"Lora-Tamayo","year":"2013","journal-title":"Clin Infect Dis."},{"issue":"4","key":"bib8-20230714","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cid\/cir402","article-title":"Outcome and predictors of treatment failure in total hip\/knee prosthetic joint infections due to Staphylococcus aureus","volume":"53","author":"Senneville","year":"2011","journal-title":"Clin Infect Dis."},{"issue":"19","key":"bib9-20230714","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","article-title":"Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial","volume":"279","author":"Zimmerli","year":"1998","journal-title":"JAMA."},{"issue":"10","key":"bib10-20230714","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1128\/AAC.00702-13","article-title":"Vancomycin-rifampin combination therapy has enhanced efficacy against an experimental Staphylococcus aureus prosthetic joint infection","volume":"57","author":"Niska","year":"2013","journal-title":"Antimicrob Agents Chemother."},{"issue":"10","key":"bib11-20230714","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1128\/AAC.00675-11","article-title":"Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus","volume":"55","author":"Saleh-Mghir","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"issue":"3","key":"bib12-20230714","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1574-695X.2010.00701.x","article-title":"Tigecycline inhibition of a mature biofilm in clinical isolates of Staphylococcus aureus : comparison with other drugs","volume":"59","author":"Cafiso","year":"2010","journal-title":"FEMS Immunol Med Microbiol."},{"issue":"4","key":"bib13-20230714","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijantimicag.2008.08.029","article-title":"Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin","volume":"33","author":"Smith","year":"2009","journal-title":"Int J Antimicrob Agents."},{"issue":"3","key":"bib14-20230714","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/jac\/dkn513","article-title":"Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus","volume":"63","author":"Rose","year":"2009","journal-title":"J Antimicrob Chemother."},{"issue":"5","key":"bib15-20230714","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/AAC.00350-06","article-title":"Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm","volume":"51","author":"Raad","year":"2007","journal-title":"Antimicrob Agents Chemother."},{"issue":"2","key":"bib16-20230714","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003088-200948020-00002","article-title":"Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations","volume":"48","author":"Landersdorfer","year":"2009","journal-title":"Clin Pharmacokinet."},{"issue":"4","key":"bib17-20230714","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ajic.2011.01.003","article-title":"Guidelines for the prevention of intravascular catheter-related infections","volume":"39","author":"O\u2019Grady","year":"2011","journal-title":"Am J Infect Control."},{"issue":"1","key":"bib18-20230714","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0885066605280884","article-title":"Mechanical complications of central venous catheters","volume":"21","author":"Eisen","year":"2006","journal-title":"J Intensive Care Med."},{"issue":"1","key":"bib19-20230714","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm."},{"issue":"4","key":"bib20-20230714","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2106\/00004623-200704000-00012","article-title":"Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030","volume":"89","author":"Kurtz","year":"2007","journal-title":"J Bone Joint Surg Am."},{"issue":"3","key":"bib21-20230714","doi-asserted-by":"crossref","first-page":"e59232","DOI":"10.1371\/journal.pone.0059232","article-title":"Stably luminescent Staphylococcus aureus clinical strains for use in bioluminescent imaging","volume":"8","author":"Plaut","year":"2013","journal-title":"PLoS One."},{"issue":"4","key":"bib22-20230714","doi-asserted-by":"crossref","first-page":"e63040","DOI":"10.1371\/journal.pone.0063040","article-title":"Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection","volume":"8","author":"Brady","year":"2013","journal-title":"PLoS One."},{"issue":"9","key":"bib23-20230714","doi-asserted-by":"crossref","first-page":"e12580","DOI":"10.1371\/journal.pone.0012580","article-title":"A mouse model of post-arthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings","volume":"5","author":"Bernthal","year":"2010","journal-title":"PLoS One."},{"issue":"3","key":"bib24-20230714","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jor.21519","article-title":"Mouse model of chronic post-arthroplasty infection: noninvasive in vivo bioluminescence imaging to monitor bacterial burden for long-term study","volume":"30","author":"Pribaz","year":"2012","journal-title":"J Orthop Res."},{"issue":"6","key":"bib25-20230714","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1046\/j.1365-2265.2003.01904.x","article-title":"Osteoporosis: pathophysiology and clinical management","volume":"59","author":"Gittoes","year":"2003","journal-title":"Clin Endocrinol (Oxf)."},{"key":"bib26-20230714","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00003086-199912000-00014","article-title":"One-stage revision surgery of the infected hip. A minimum 10-year followup study","volume":"369","author":"Callaghan","year":"1999","journal-title":"Clin Orthop Relat Res."},{"key":"bib27-20230714","first-page":"447","article-title":"Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin","volume":"5","author":"Stephens","year":"2013","journal-title":"Clinicoecon Outcomes Res."},{"issue":"Suppl 2","key":"bib28-20230714","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1086\/653520","article-title":"Outpatient parenteral antimicrobial therapy today","volume":"51","author":"Paladino","year":"2010","journal-title":"Clin Infect Dis."},{"issue":"4","key":"bib29-20230714","doi-asserted-by":"crossref","first-page":"ftw019","DOI":"10.1093\/femspd\/ftw019","article-title":"Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro","volume":"74","author":"J\u00f8rgensen","year":"2016","journal-title":"Pathog Dis."},{"issue":"3","key":"bib30-20230714","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1128\/AAC.00775-08","article-title":"Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection","volume":"53","author":"Baldoni","year":"2009","journal-title":"Antimicrob Agents Chemother."},{"issue":"9","key":"bib31-20230714","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1128\/AAC.00352-11","article-title":"Linezolid plus rifampin as a salvage therapy in prosthetic joint infections treated without removing the implant","volume":"55","author":"G\u00f3mez","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"issue":"8","key":"bib32-20230714","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/AAC.46.8.2723-2726.2002","article-title":"Hematologic effects of linezolid: summary of clinical experience","volume":"46","author":"Gerson","year":"2002","journal-title":"Antimicrob Agents Chemother."},{"issue":"11","key":"bib33-20230714","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.1128\/AAC.03600-14","article-title":"Ceftaroline-fosamil efficacy against methicillin-resistant Staphylococcus aureus in a rabbit prosthetic joint infection model","volume":"58","author":"Gatin","year":"2014","journal-title":"Antimicrob Agents Chemother."},{"issue":"3","key":"bib34-20230714","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.diagmicrobio.2014.11.016","article-title":"Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USA","volume":"81","author":"Stryjewski","year":"2015","journal-title":"Diagn Microbiol Infect Dis."},{"issue":"2","key":"bib35-20230714","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/sj.clpt.6100247","article-title":"The challenge of treating biofilm-associated bacterial infections","volume":"82","author":"del Pozo","year":"2007","journal-title":"Clin Pharmacol Ther."},{"issue":"1","key":"bib36-20230714","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1128\/JCM.01766-13","article-title":"Optimal culture incubation time in orthopedic device-associated infections: a retrospective analysis of prolonged 14-day incubation","volume":"52","author":"Schwotzer","year":"2014","journal-title":"J Clin Microbiol."},{"issue":"Pt 8","key":"bib37-20230714","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1099\/jmm.0.009720-0","article-title":"Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study","volume":"58","author":"Singh","year":"2009","journal-title":"J Med Microbiol."},{"issue":"4","key":"bib38-20230714","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1128\/AAC.50.4.1376-1383.2006","article-title":"Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target","volume":"50","author":"Andes","year":"2006","journal-title":"Antimicrob Agents Chemother."},{"issue":"7","key":"bib39-20230714","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jcph.265","article-title":"A series of pharmacokinetic studies of ceftaroline fosamil in select populations: normal subjects, healthy elderly subjects, and subjects with renal impairment or end-stage renal disease requiring hemodialysis","volume":"54","author":"Riccobene","year":"2014","journal-title":"J Clin Pharmacol."},{"issue":"6","key":"bib40-20230714","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1128\/AAC.01046-07","article-title":"Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models","volume":"52","author":"LaPlante","year":"2008","journal-title":"Antimicrob Agents Chemother."},{"issue":"2","key":"bib41-20230714","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1128\/AAC.05606-11","article-title":"Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis","volume":"56","author":"Dom\u00ednguez-Herrera","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"issue":"2","key":"bib42-20230714","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1128\/AAC.36.2.318","article-title":"Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers","volume":"36","author":"Woodworth","year":"1992","journal-title":"Antimicrob Agents Chemother."},{"issue":"2","key":"bib43-20230714","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J Antimicrob Chemother."},{"issue":"1","key":"bib44-20230714","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/jac\/dkm417","article-title":"Efficacy of telavancin in a murine model of pneumonia induced by methicillin-susceptible Staphylococcus aureus","volume":"61","author":"Hegde","year":"2008","journal-title":"J Antimicrob Chemother."},{"issue":"11","key":"bib45-20230714","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1128\/AAC.46.11.3484-3489.2002","article-title":"In vivo pharmacodynamics of a new oxazolidinone (linezolid)","volume":"46","author":"Andes","year":"2002","journal-title":"Antimicrob Agents Chemother."},{"issue":"2","key":"bib46-20230714","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/AAC.47.2.548-553.2003","article-title":"Population pharmacokinetics of linezolid in patients treated in a compassionate-use program","volume":"47","author":"Meagher","year":"2003","journal-title":"Antimicrob Agents Chemother."},{"issue":"12","key":"bib47-20230714","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1128\/AAC.00062-10","article-title":"Comparative efficacies of human simulated exposures of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a range of vancomycin MICs in a murine pneumonia model","volume":"54","author":"Crandon","year":"2010","journal-title":"Antimicrob Agents Chemother."},{"issue":"3","key":"bib48-20230714","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1128\/AAC.31.3.393","article-title":"Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers","volume":"31","author":"Healy","year":"1987","journal-title":"Antimicrob Agents Chemother."},{"issue":"10","key":"bib49-20230714","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1164\/rccm.201207-1210OC","article-title":"Optimization of the rifampin dosage to improve the therapeutic efficacy in tuberculosis treatment using a murine model","volume":"187","author":"de Steenwinkel","year":"2013","journal-title":"Am J Respir Crit Care Med."},{"issue":"7","key":"bib50-20230714","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1128\/AAC.01550-06","article-title":"Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients","volume":"51","author":"Ruslami","year":"2007","journal-title":"Antimicrob Agents Chemother."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004623-201704190-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:38:58Z","timestamp":1787751538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004623-201704190-00005"}},"subtitle":["Study of a Mouse Model"],"short-title":[],"issued":{"date-parts":[[2017,4,19]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.16.01002","relation":{},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,19]]}}}